GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai Kehua Bio-engineering Co Ltd (SZSE:002022) » Definitions » EV-to-EBITDA

Shanghai Kehua Bio-engineering Co (SZSE:002022) EV-to-EBITDA : -9.68 (As of May. 25, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Shanghai Kehua Bio-engineering Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Shanghai Kehua Bio-engineering Co's enterprise value is ¥2,720 Mil. Shanghai Kehua Bio-engineering Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-281 Mil. Therefore, Shanghai Kehua Bio-engineering Co's EV-to-EBITDA for today is -9.68.

The historical rank and industry rank for Shanghai Kehua Bio-engineering Co's EV-to-EBITDA or its related term are showing as below:

SZSE:002022' s EV-to-EBITDA Range Over the Past 10 Years
Min: -61.33   Med: 20.65   Max: 83.92
Current: -9.68

During the past 13 years, the highest EV-to-EBITDA of Shanghai Kehua Bio-engineering Co was 83.92. The lowest was -61.33. And the median was 20.65.

SZSE:002022's EV-to-EBITDA is ranked worse than
100% of 488 companies
in the Medical Devices & Instruments industry
Industry Median: 16.205 vs SZSE:002022: -9.68

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-25), Shanghai Kehua Bio-engineering Co's stock price is ¥6.83. Shanghai Kehua Bio-engineering Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-0.618. Therefore, Shanghai Kehua Bio-engineering Co's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Shanghai Kehua Bio-engineering Co EV-to-EBITDA Historical Data

The historical data trend for Shanghai Kehua Bio-engineering Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Kehua Bio-engineering Co EV-to-EBITDA Chart

Shanghai Kehua Bio-engineering Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.42 5.04 3.90 2.07 75.89

Shanghai Kehua Bio-engineering Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.59 2.35 -47.77 75.89 -14.67

Competitive Comparison of Shanghai Kehua Bio-engineering Co's EV-to-EBITDA

For the Medical Devices subindustry, Shanghai Kehua Bio-engineering Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Kehua Bio-engineering Co's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shanghai Kehua Bio-engineering Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Shanghai Kehua Bio-engineering Co's EV-to-EBITDA falls into.



Shanghai Kehua Bio-engineering Co EV-to-EBITDA Calculation

Shanghai Kehua Bio-engineering Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=2720.137/-281.082
=-9.68

Shanghai Kehua Bio-engineering Co's current Enterprise Value is ¥2,720 Mil.
Shanghai Kehua Bio-engineering Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-281 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Kehua Bio-engineering Co  (SZSE:002022) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Shanghai Kehua Bio-engineering Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=6.83/-0.618
=At Loss

Shanghai Kehua Bio-engineering Co's share price for today is ¥6.83.
Shanghai Kehua Bio-engineering Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.618.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Shanghai Kehua Bio-engineering Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Shanghai Kehua Bio-engineering Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Kehua Bio-engineering Co (SZSE:002022) Business Description

Traded in Other Exchanges
N/A
Address
No. 1189 Qinzhou North Road, Xuhui District, Shanghai, CHN, 200233
Shanghai Kehua Bio-engineering Co Ltd is a developer, manufacturer, and marketer of in-vitro diagnostics business in China. Its products are mainly offered in two primary business segments: Diagnostic Reagents and Diagnostic Laboratory Instruments. Its products include diagnostic reagents, such as enzyme-immunoassay kits, clinical chemistry reagents, PCR kits, and rapid test kits and lab-instruments comprising chemistry analyzers, microplate washers/readers, electrolyte analyzers, and nucleic acid extractors.
Executives
Li Ming Executives
He Jian Wen Executives
Ji Yu Ming Supervisors
Li Ji Executives
Sha Li Wu Director
Wang Man Directors, executives
Tang Wei Guo Director

Shanghai Kehua Bio-engineering Co (SZSE:002022) Headlines

No Headlines